Physician profile
Adens Previlon
NPI 1033142591
$2,226.86
in general payments reported to CMS, 2019-2025
15 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $292 · 2022: $276 · 2023: $665 · 2024: $408 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $492.09 | 2021-2025 | Breztri, Fasenra |
| Actelion Pharmaceuticals US, INC. | $343.71 | 2023-2024 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $300.20 | 2023-2025 | Dupixent |
| United Therapeutics Corporation | $277.90 | 2021-2025 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $185.24 | 2022-2024 | Acthar |
| Mylan Specialty L.P. | $152.76 | 2021-2024 | Yupelri |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Nucala |
| Viatris Specialty LLC | $122.15 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.85 | 2022-2024 | Ofev, Spiriva |
| Takeda Pharmaceuticals U.S.A., INC. | $60.34 | 2022 | |
| Baxter Healthcare | $25.21 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Janssen Pharmaceuticals, INC | $21.40 | 2022 | |
| Verona Pharma, INC. | $19.38 | 2025 | Ohtuvayre |
| Phadia US INC. | $16.60 | 2023 | Immunocap |
| Novartis Pharmaceuticals Corporation | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adens Previlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.